We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Tristel Plc (TSTL) Ordinary 1p Shares

Sell:420.00p Buy:435.00p 0 Change: 5.00p (1.18%)
FTSE AIM 100:0.15%
Market closed Prices as at close on 28 May 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 5.00p (1.18%)
Market closed Prices as at close on 28 May 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 5.00p (1.18%)
Market closed Prices as at close on 28 May 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Tristel plc is a United Kingdom-based manufacturer of infection prevention products. The Company's core business is the sale to hospitals of its chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand, and for the sporicidal disinfection of environmental surfaces under the Cache brand. The Company operates through three segments: Hospital medical device decontamination, Hospital environmental surface disinfection and others. It manufactures and sells medical device decontamination products which are used primarily for infection control in hospitals. The Company also manufactures and sells hospital environmental surface disinfection products. The Company is also focused on pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare sectors. The Tristel brand offers airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal (GI) physiology, laboratory, ophthalmology, and ultrasound.

Contact details

Lynx Business Park,Fordham Road
United Kingdom
+44 (01638) 721500

Important dates

Future events
There are no future events available.
Past events
Interim dividend payment date 12 April 2024 12/04/24
Interim ex-dividend date 21 March 2024 21/03/24
Interim results 26 February 2024 26/02/24
Final dividend payment date 22 December 2023 22/12/23
AGM 19 December 2023 19/12/23
Final ex-dividend date 23 November 2023 23/11/23
Final results 16 October 2023 16/10/23
Trading Announcement 25 July 2023 25/07/23

General stock information

Market cap:
£203.22 million
Shares in issue:
47.54 million
Health Care Equipment & Services
London Stock Exchange
Sterling pence

Key personnel

  • Paul Swinney
    Chief Executive Officer, Executive Director
  • Elizabeth Dixon
    Chief Financial Officer, Finance Director, Executive Director
  • Heidi Allard
    Group Financial Controller, Company Secretary
  • Bart Leemans
    Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.